89 related articles for article (PubMed ID: 20025546)
1. Signaling defects and functional impairment in T-cells from cervical cancer patients.
Cheriyan VT; Krishna SM; Kumar A; Jayaprakash PG; Balaram P
Cancer Biother Radiopharm; 2009 Dec; 24(6):667-73. PubMed ID: 20025546
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer.
Kono K; Ressing ME; Brandt RM; Melief CJ; Potkul RK; Andersson B; Petersson M; Kast WM; Kiessling R
Clin Cancer Res; 1996 Nov; 2(11):1825-8. PubMed ID: 9816136
[TBL] [Abstract][Full Text] [Related]
3. The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease.
Frydecka I; Boćko D; Kosmaczewska A; Ciszak L; Morilla R
Br J Cancer; 2001 May; 84(10):1339-43. PubMed ID: 11355944
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of T-cell immune responses and signal transduction proteins in oral cancer patients: potential for IL-2-mediated immunotherapy.
Cheriyan VT; Thomas C; Balaram P
J Cancer Res Clin Oncol; 2011 Oct; 137(10):1435-44. PubMed ID: 21809032
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
6. Increased production of interleukin-6 by T lymphocytes from patients with multiple myeloma.
Lapeña P; Prieto A; Garcia-Suarez J; Reyes E; San Miguel J; Jorda J; Alvarez-Mon M
Exp Hematol; 1996 Jan; 24(1):26-30. PubMed ID: 8536788
[TBL] [Abstract][Full Text] [Related]
7. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy.
Rabinowich H; Banks M; Reichert TE; Logan TF; Kirkwood JM; Whiteside TL
Clin Cancer Res; 1996 Aug; 2(8):1263-74. PubMed ID: 9816296
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes.
de Gruijl TD; Bontkes HJ; Peccatori F; Gallee MP; Helmerhorst TJ; Verheijen RH; Aarbiou J; Mulder WM; Walboomers JM; Meijer CJ; van de Vange N; Scheper RJ
Br J Cancer; 1999 Mar; 79(7-8):1127-32. PubMed ID: 10098746
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated immunity in patients with invasive carcinoma of the cervix.
Park TK; Kim SN
Yonsei Med J; 1989; 30(2):164-72. PubMed ID: 2800566
[TBL] [Abstract][Full Text] [Related]
10. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients.
Emingil G; Karaarslan F; Keskinoğlu A; Coker I; Atilla G
J Int Acad Periodontol; 2001 Oct; 3(4):87-94. PubMed ID: 12666947
[TBL] [Abstract][Full Text] [Related]
12. Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis.
Chen X; Woiciechowsky A; Raffegerst S; Schendel D; Kolb HJ; Roskrow M
Br J Haematol; 2000 Dec; 111(3):817-25. PubMed ID: 11122143
[TBL] [Abstract][Full Text] [Related]
13. Circulating T cells in patients with untreated acute myelogenous leukemia are heterogeneous and can be activated through the CD3/TCR complex.
Ersvaer E; Hampson P; Wendelbo Ø; Lord JM; Gjertsen BT; Bruserud Ø
Hematology; 2007 Jun; 12(3):199-207. PubMed ID: 17558695
[TBL] [Abstract][Full Text] [Related]
14. IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes.
Romano MF; Lamberti A; Petrella A; Bisogni R; Tassone PF; Formisano S; Venuta S; Turco MC
J Immunol; 1996 Mar; 156(6):2119-23. PubMed ID: 8690900
[TBL] [Abstract][Full Text] [Related]
15. Peripheral T lymphocytes from women with breast cancer exhibit abnormal protein expression of several signaling molecules.
Kurt RA; Urba WJ; Smith JW; Schoof DD
Int J Cancer; 1998 Sep; 78(1):16-20. PubMed ID: 9724088
[TBL] [Abstract][Full Text] [Related]
16. Decreased c-rel activation contributes to aberrant interleukin-2 expression in CD4(+)T cells of aged rats.
Gong Z; Liu T; Wan Y; Hang Z; Tong X; Zhang B; Yang H; Zhang X; Zhang L; Jin G
Mol Immunol; 2014 Sep; 61(1):1-6. PubMed ID: 24853588
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
[TBL] [Abstract][Full Text] [Related]
18. Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients.
Dieckhoff K; Graf P; Beinhauer B; Schwaerzler C; Carballido JM; Neumann C; Zachmann K; Jung T
Exp Dermatol; 2005 Jan; 14(1):17-25. PubMed ID: 15660915
[TBL] [Abstract][Full Text] [Related]
19. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL
Clin Cancer Res; 1996 Jan; 2(1):161-73. PubMed ID: 9816103
[TBL] [Abstract][Full Text] [Related]
20. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
